| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0089 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0092 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |